These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24708385)

  • 1. Limited efficacy of West Nile virus vaccines in large falcons (Falco spp.).
    Angenvoort J; Fischer D; Fast C; Ziegler U; Eiden M; de la Fuente JG; Lierz M; Groschup MH
    Vet Res; 2014 Apr; 45(1):41. PubMed ID: 24708385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines encoding the envelope protein of West Nile virus lineages 1 or 2 administered intramuscularly, via electroporation and with recombinant virus protein induce partial protection in large falcons (Falco spp.).
    Fischer D; Angenvoort J; Ziegler U; Fast C; Maier K; Chabierski S; Eiden M; Ulbert S; Groschup MH; Lierz M
    Vet Res; 2015 Aug; 46(1):87. PubMed ID: 26282836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis).
    Redig PT; Tully TN; Ritchie BW; Roy AF; Baudena MA; Chang GJ
    Am J Vet Res; 2011 Aug; 72(8):1065-70. PubMed ID: 21801064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
    Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC
    Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response in horses following West Nile virus vaccination with inactivated or recombinant vaccine.
    Monaco F; Purpari G; Di Gennaro A; Mira F; Di Marco P; Guercio A; Savini G
    Vet Ital; 2019 Mar; 55(1):73-79. PubMed ID: 30951184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
    Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
    Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of West Nile virus lineage 1 and 2 in experimentally infected large falcons.
    Ziegler U; Angenvoort J; Fischer D; Fast C; Eiden M; Rodriguez AV; Revilla-Fernández S; Nowotny N; de la Fuente JG; Lierz M; Groschup MH
    Vet Microbiol; 2013 Jan; 161(3-4):263-73. PubMed ID: 22909991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
    Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
    Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of three vaccines in protecting Western Scrub-Jays (Aphelocoma californica) from experimental infection with West Nile virus: implications for vaccination of Island Scrub-Jays (Aphelocoma insularis).
    Wheeler SS; Langevin S; Woods L; Carroll BD; Vickers W; Morrison SA; Chang GJ; Reisen WK; Boyce WM
    Vector Borne Zoonotic Dis; 2011 Aug; 11(8):1069-80. PubMed ID: 21438693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of captive nēnē (Branta sandvicensis) against West Nile virus using a protein-based vaccine (WN-80E).
    Jarvi SI; Hu D; Misajon K; Coller BA; Wong T; Lieberman MM
    J Wildl Dis; 2013 Jan; 49(1):152-6. PubMed ID: 23307381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental West Nile virus infection in Gyr-Saker hybrid falcons.
    Busquets N; Bertran K; Costa TP; Rivas R; de la Fuente JG; Villalba R; Solanes D; Bensaid A; Majó N; Pagès N
    Vector Borne Zoonotic Dis; 2012 Jun; 12(6):482-9. PubMed ID: 22448746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of horses from West Nile virus Lineage 2 challenge following immunization with a whole, inactivated WNV lineage 1 vaccine.
    Bowen RA; Bosco-Lauth A; Syvrud K; Thomas A; Meinert TR; Ludlow DR; Cook C; Salt J; Ons E
    Vaccine; 2014 Sep; 32(42):5455-9. PubMed ID: 25131745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of West Nile virus and response to vaccination in sandhill cranes (Grus canadensis) using a killed vaccine.
    Olsen GH; Miller KJ; Docherty DE; Bochsler VS; Sileo L
    J Zoo Wildl Med; 2009 Jun; 40(2):263-71. PubMed ID: 19569472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.
    Venter M; van Vuren PJ; Mentoor J; Paweska J; Williams J
    Vaccine; 2013 Aug; 31(37):3856-62. PubMed ID: 23820079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
    Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).
    Wolf TM; Gandolf AR; Dooley JL; Atkinson MW; Wolfe BA
    J Zoo Wildl Med; 2008 Dec; 39(4):537-41. PubMed ID: 19110693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.